Neuroprotective changes of thalamic degeneration-related gene expression by acupuncture in an MPTP mouse model of parkinsonism: Microarray analysis

Gene

Volumn 515, Issue 2, 2013, Pages 329-338

  Yeo, Sujung ^a   Choi, Yeong Gon ^a   Hong, Yeon Mi ^a   Lim, Sabina ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Acupoints; Differentially expressed genes; Gene array; Neurodegeneration; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DEOXYRIBONUCLEASE I; DEOXYRIBONUCLEASE II; DUSP4 PROTEIN; MEMBRANE PROTEIN; TRANSCRIPTION FACTOR MAFG; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ACUPUNCTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEGENERATION; BRAIN REGION; CONTROLLED STUDY; GENE EXPRESSION; MALE; MICROARRAY ANALYSIS; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSONISM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THALAMUS; VALIDATION PROCESS;

ACUPUNCTURE THERAPY; ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; THALAMUS; TRANSCRIPTOME; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 84872490421     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.12.002     Document Type: Article

References (73)

1. Aheng C., et al. Deletion of UCP2 in iNOS deficient mice reduces the severity of the disease during experimental autoimmune encephalomyelitis. PLoS One 2011, 6:e22841.
2. Al-Mutairi M.S., et al. MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana. PLoS Pathog. 2010, 6:e1001192.
3. An J.H., Lee S.Y., Jeon J.Y., Cho K.G., Kim S.U., Lee M.A. Identification of gliotropic factors that induce human stem cell migration to malignant tumor. J. Proteome Res. 2009, 8:2873-2881.
4. Andrews Z.B., et al. Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease. J. Neurosci. 2005, 25:184-191.
5. Andrews Z.B., et al. Uncoupling protein-2 promotes nigrostriatal dopamine neuronal function. Eur. J. Neurosci. 2006, 24:32-36.
6. Andrews Z.B., et al. Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J. Neurosci. 2009, 29:14057-14065.
7. Aymerich M.S., et al. Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats. Eur. J. Neurosci. 2006, 23:2099-2108.
8. Belkin A.M., Burridge K. Association of aciculin with dystrophin and utrophin. J. Biol. Chem. 1995, 270:6328-6337.
9. Belkin A.M., Klimanskaya I.V., Lukashev M.E., Lilley K., Critchley D.R., Koteliansky V.E. A novel phosphoglucomutase-related protein is concentrated in adherens junctions of muscle and nonmuscle cells. J. Cell Sci. 1994, 107(Pt 1):159-173.
10. Berger W., et al. Mutations in the candidate gene for Norrie disease. Hum. Mol. Genet. 1992, 1:461-465.
11. Bezard E., Dovero S., Bioulac B., Gross C. Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. Exp. Neurol. 1997, 148:288-292.
12. Braak H., Del Tredici K. Invited article: nervous system pathology in sporadic Parkinson disease. Neurology 2008, 70:1916-1925.
13. Brewer J.W., Diehl J.A. PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12625-12630.
14. Brooks D., Halliday G.M. Intralaminar nuclei of the thalamus in Lewy body diseases. Brain Res. Bull. 2009, 78:97-104.
15. Byers B., et al. SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate alpha-synuclein and are susceptible to oxidative stress. PLoS One 2011, 6:e26159.
16. Cebrian C., Prensa L. Basal ganglia and thalamic input from neurons located within the ventral tier cell cluster region of the substantia nigra pars compacta in the rat. J. Comp. Neurol. 2010, 518:1283-1300.
17. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
18. Chauhan N.B., Siegel G.J., Lee J.M. Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain. J. Chem. Neuroanat. 2001, 21:277-288.
19. Choi Y.G., Park J.H., Lim S. Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced parkinsonism model. Neurosci. Lett. 2009, 450:92-96.
20. Choi Y.G., Yeo S., Hong Y.M., Kim S.H., Lim S. Changes of gene expression profiles in the cervical spinal cord by acupuncture in an MPTP-intoxicated mouse model: microarray analysis. Gene 2011, 481:7-16.
21. Choi Y.G., Yeo S., Hong Y.M., Lim S. Neuroprotective changes of striatal degeneration-related gene expression by acupuncture in an MPTP mouse model of Parkinsonism: microarray analysis. Cell. Mol. Neurobiol. 2011, 31:377-391.
22. Choi D.H., et al. NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease. Antioxid. Redox Signal. 2012, 16:1033-1045.
23. Conti B., et al. Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity. J. Neurochem. 2005, 93:493-501.
24. Cullinan S.B., Zhang D., Hannink M., Arvisais E., Kaufman R.J., Diehl J.A. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell. Biol. 2003, 23:7198-7209.
25. de Haan J.B., et al. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J. Biol. Chem. 1998, 273:22528-22536.
26. Deierborg T., Wieloch T., Diano S., Warden C.H., Horvath T.L., Mattiasson G. Overexpression of UCP2 protects thalamic neurons following global ischemia in the mouse. J. Cereb. Blood Flow Metab. 2008, 28:1186-1195.
27. Fernandez-Espejo E. Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies. Mol. Neurobiol. 2004, 29:15-30.
28. Fischer H., et al. DNase1L2 degrades nuclear DNA during corneocyte formation. J. Invest. Dermatol. 2007, 127:24-30.
29. Fischer H., et al. Essential role of the keratinocyte-specific endonuclease DNase1L2 in the removal of nuclear DNA from hair and nails. J. Invest. Dermatol. 2011, 131:1208-1215.
30. Freyaldenhoven T.E., Ali S.F., Schmued L.C. Systemic administration of MPTP induces thalamic neuronal degeneration in mice. Brain Res. 1997, 759:9-17.
31. Goto S., Hirano A., Matsumoto S. Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration. Ann. Neurol. 1989, 26:766-770.
32. Gross R.E., Jones E.G., Dostrovsky J.O., Bergeron C., Lang A.E., Lozano A.M. Histological analysis of the location of effective thalamic stimulation for tremor. Case report. J. Neurosurg. 2004, 100:547-552.
33. Halliday G.M. Thalamic changes in Parkinson's disease. Parkinsonism Relat. Disord. 2009, 15(Suppl. 3):S152-S155.
34. Halliday G.M., Macdonald V., Henderson J.M. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. Brain 2005, 128:2272-2280.
35. Holmstrand E.C., Sesack S.R. Projections from the rat pedunculopontine and laterodorsal tegmental nuclei to the anterior thalamus and ventral tegmental area arise from largely separate populations of neurons. Brain Struct. Funct. 2011, 216:331-345.
36. Huang C.Y., Lin Y.C., Hsiao W.Y., Liao F.H., Huang P.Y., Tan T.H. DUSP4 deficiency enhances CD25 expression and CD4(+) T-cell proliferation without impeding T-cell development. Eur. J. Immunol. 2012, 42:476-488.
37. Hunter R.L., Choi D.Y., Ross S.A., Bing G. Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats. Neurosci. Lett. 2008, 432:198-201.
38. Hwang S.H., Choi Y.G., Jeong M.Y., Hong Y.M., Lee J.H., Lim S. Microarray analysis of gene expression profile by treatment of Cinnamomi Ramulus in lipopolysaccharide-stimulated BV-2 cells. Gene 2009, 443:83-90.
39. Inuzuka M., Hayakawa M., Ingi T. Serinc, an activity-regulated protein family, incorporates serine into membrane lipid synthesis. J. Biol. Chem. 2005, 280:35776-35783.
40. Jellinger K.A. Synuclein deposition and non-motor symptoms in Parkinson disease. J. Neurol. Sci. 2011, 310:107-111.
41. Kang J.M., et al. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model. Brain Res. 2007, 1131:211-219.
42. Kassubek J., Juengling F.D., Hellwig B., Spreer J., Lucking C.H. Thalamic gray matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neurosci. Lett. 2002, 323:29-32.
43. Katsuoka F., et al. Small Maf compound mutants display central nervous system neuronal degeneration, aberrant transcription, and Bach protein mislocalization coincident with myoclonus and abnormal startle response. Mol. Cell. Biol. 2003, 23:1163-1174.
44. Katsuoka F., Motohashi H., Engel J.D., Yamamoto M. Nrf2 transcriptionally activates the mafG gene through an antioxidant response element. J. Biol. Chem. 2005, 280:4483-4490.
45. Katsuoka F., Motohashi H., Ishii T., Aburatani H., Engel J.D., Yamamoto M. Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes. Mol. Cell. Biol. 2005, 25:8044-8051.
46. Kim T.H., Chiera S.L., Linder K.E., Trempus C.S., Smart R.C., Horowitz J.M. Overexpression of transcription factor sp2 inhibits epidermal differentiation and increases susceptibility to wound- and carcinogen-induced tumorigenesis. Cancer Res. 2010, 70:8507-8516.
47. Kitahama K., Okamura H., Goldstein M., Nagatsu I., Berod A., Jouvet M. A new group of tyrosine hydroxylase-immunoreactive neurons in the cat thalamus. Brain Res. 1989, 478:156-160.
48. Kuhn K., Wellen J., Link N., Maskri L., Lubbert H., Stichel C.C. The mouse MPTP model: gene expression changes in dopaminergic neurons. Eur. J. Neurosci. 2003, 17:1-12.
49. Li W., Liu J., Skidmore F., Liu Y., Tian J., Li K. White matter microstructure changes in the thalamus in Parkinson disease with depression: a diffusion tensor MR imaging study. AJNR Am. J. Neuroradiol. 2010, 31:1861-1866.
50. Lin H.Q., Choi R., Chan K.L., Ip D., Tsim K.W., Wan D.C. Differential gene expression profiling on the muscle of acetylcholinesterase knockout mice: a preliminary analysis. Chem. Biol. Interact. 2010, 187:120-123.
51. Liu G., et al. Alpha-synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci. Lett. 2009, 454:187-192.
52. Lubos E., et al. Glutathione peroxidase-1 deficiency augments proinflammatory cytokine-induced redox signaling and human endothelial cell activation. J. Biol. Chem. 2011, 286:35407-35417.
53. Meindl A., et al. Norrie disease is caused by mutations in an extracellular protein resembling C-terminal globular domain of mucins. Nat. Genet. 1992, 2:139-143.
54. Ni Z., Pinto A.D., Lang A.E., Chen R. Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann. Neurol. 2010, 68:816-824.
55. Ohlmann A.V., Adamek E., Ohlmann A., Lutjen-Drecoll E. Norrie gene product is necessary for regression of hyaloid vessels. Invest. Ophthalmol. Vis. Sci. 2004, 45:2384-2390.
56. Pardridge W.M. Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy. NeuroRx 2005, 2:129-138.
57. Park H.J., et al. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model. Exp. Neurol. 2003, 180:93-98.
58. Pessiglione M., et al. Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits. J. Neurosci. 2005, 25:1523-1531.
59. Phan D., et al. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res. 2004, 64:3072-3078.
60. Player A., et al. Identification of TDE2 gene and its expression in non-small cell lung cancer. Int. J. Cancer 2003, 107:238-243.
61. Rehm H.L., et al. Vascular defects and sensorineural deafness in a mouse model of Norrie disease. J. Neurosci. 2002, 22:4286-4292.
62. Rub U., et al. Parkinson's disease: the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology. Neurobiol. Aging 2002, 23:245-254.
63. Seitz R., Hackl S., Seibuchner T., Tamm E.R., Ohlmann A. Norrin mediates neuroprotective effects on retinal ganglion cells via activation of the Wnt/beta-catenin signaling pathway and the induction of neuroprotective growth factors in Muller cells. J. Neurosci. 2010, 30:5998-6010.
64. Shavit J.A., Motohashi H., Onodera K., Akasaka J., Yamamoto M., Engel J.D. Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice. Genes Dev. 1998, 12:2164-2174.
65. Singleton A.B., et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
66. Smith Y., Raju D.V., Pare J.F., Sidibe M. The thalamostriatal system: a highly specific network of the basal ganglia circuitry. Trends Neurosci. 2004, 27:520-527.
67. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6469-6473.
68. Teng C.H., Huang W.N., Meng T.C. Several dual specificity phosphatases coordinate to control the magnitude and duration of JNK activation in signaling response to oxidative stress. J. Biol. Chem. 2007, 282:28395-28407.
69. Truong L., Brooks D., Amaral F., Henderson J.M., Halliday G.M. Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia. Mov. Disord. 2009, 24:2128-2135.
70. Wakabayashi K., Matsumoto K., Takayama K., Yoshimoto M., Takahashi H. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci. Lett. 1997, 239:45-48.
71. Yin H., Nichols T.D., Horowitz J.M. Transcription of mouse Sp2 yields alternatively spliced and sub-genomic mRNAs in a tissue- and cell-type-specific fashion. Biochim. Biophys. Acta 2010, 1799:520-531.
72. Yu Y.P., Ju W.P., Li Z.G., Wang D.Z., Wang Y.C., Xie A.M. Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat. Brain Res. 2010, 1336:58-65.
73. Zhou J., et al. Changes in the solubility and phosphorylation of alpha-synuclein over the course of Parkinson's disease. Acta Neuropathol. 2011, 121:695-704.